Poly(I:C), a synthetic analog of viral double-stranded RNA (dsRNA), is a TLR3 agonist that induces efficient anticancer activity acting on macrophages, by promoting a switch from M2 to M1 phenotype, eventually reducing tumor growth [23, 24]. The gene discussed is TLR3; the disease is neoplasm.